Overview

Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetics of donepezil HCl 3 mg in subjects with end-state renal disease who were receiving haemodialysis.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Donepezil